Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC. (Q37687273)
Jump to navigation
Jump to search
scientific article published on 15 September 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC. |
scientific article published on 15 September 2016 |
Statements
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC (English)
Giovanni Scambia
Antonella Savarese
Simona Signoriello
Roberto Sorio
Stefano Tamberi
Ciro Gallo
Francesco Perrone
Gennaro Chiappetta
Franca Esposito
Renato Franco
Gian F Zannoni
Enrico Breda
Paolo Scollo
Antonella Ferro
Antonio Febbraro
Donato Natale
Massimo Di Maio
Silvana Canevari
1 reference